This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

4 Stocks Under $5 Soaring Higher

Zogenix

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Zogenix (ZGNX - Get Report) is a specialty pharmaceutical company with two product candidates in late-stage development for the treatment of central nervous system disorders and pain. This stock is trading up 13.2% to $1.80 in recent trading.

Today's Range: $1.59-$1.88

52-Week Range: $1.31-$5.11

Volume: 249,000

Three-Month Average Volume: 358,306

Shares of ZGNX are soaring today after the company submitted an investigational new drug application to the FDA for Relday, which is a combination of its DosePro needle-free, subcutaneous drug delivery system plus a proprietary, subcutaneous once-monthly formulation of risperidone for treating schizophrenia.

>>22 Biopharma Stocks With Breakout Potential

From a technical perspective, ZGNX is bouncing hard here off some near-term support at $1.55 to $1.60 with decent volume. This move has pushed ZGNZ right below its 50-day moving average of $1.90.

Traders should now look for long-biased trades in ZGNX if it can manage to take out its 50-day at $1.90, and then some major overhead resistance at $2.28 with high volume. Look for a sustained move or close above $1.90 to $2.28 with volume that's near or above 358,306 shares. If we get that action soon, then ZGNZ has a great chance of re-testing its March high of $2.90.
2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
LDK $0.00 0.00%
ZGNX $13.03 0.00%
FCEL $0.90 0.00%
ISR $1.46 0.00%
AAPL $126.00 0.00%

Markets

DOW 17,683.58 -46.53 -0.26%
S&P 500 2,068.76 -8.02 -0.39%
NASDAQ 4,991.94 -17.2740 -0.34%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs